To provide a portfolio designed to achieve high and rising income.
Name | % Net Assets |
---|---|
Pfizer | 3.5% |
Altria | 3.1% |
Vodafone | 2.9% |
Zurich Financial Services | 2.4% |
Coca-Cola | 2.4% |
Mcdonalds | 2.4% |
Total | 2.4% |
British American Tobacco | 2.4% |
Unilever | 2.3% |
Merck & Co | 2.3% |
Key | % Net Assets |
---|---|
Pfizer | 3.5% |
Altria | 3.1% |
Vodafone | 2.9% |
Zurich Financial Services | 2.4% |
Other | 88.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 233.30p |
Currency | GBP |
Change | -0.60p |
% | -0.26% |
YTD change | 22.10p |
YTD % | 10.46% |
Fund Inception | 07/02/2007 |
---|---|
Fund Manager | Gerd Woort-Menker |
TER | 0.93 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £5000000 |
Additional | £100,000 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research